Atlas Trials

Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy

Clinical trial NCT02348073 · COMPLETED

Trial details

NCT number
NCT02348073
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Attention Deficit Disorder With HyperactivityADHD Inattention or Mixed TypeEpilepsyChild
Start date
2015-03-01
Primary completion
2018-10-01
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.